Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.8.0.1
Stockholders' Equity
9 Months Ended
Aug. 31, 2017
Equity [Abstract]  
Stockholders' Equity

Note 8 – Stockholders’ Equity

Employee Stock Incentive Plan

The Company maintains the 2006 Stock Incentive Plan (the “2006 Plan”) under which it has reserved 1,000,000 shares of the Company’s common stock for issuance pursuant to stock options, restricted stock, stock-appreciation rights (commonly referred to as “SARs”) and stock awards (i.e. performance options to purchase shares and performance units). As of August 31, 2017 and November 30, 2016, there were 560,500 and 572,281 options issued, but not yet exercised, under the 2006 Plan, respectively. As of August 31, 2017, there were 211,929 shares available for future issuance under the 2006 Plan.

The Company also maintains the 2012 Equity Incentive Plan (the “2012 Plan”) which became effective December 1, 2011 as approved by the Board of Directors and approved by the stockholders at the 2012 Annual Meeting on July 10, 2012. The 2012 Plan originally reserved 1,500,000 shares of the Company’s common stock for issuance pursuant to stock options, restricted stock, SARs, and other stock awards (i.e. performance shares and performance units). In May 2012, the Board of Directors approved an amendment to the 2012 Plan to increase the number of shares of the Company’s common stock reserved for issuance to 2,500,000 shares. As of August 31, 2017, there were 569,729 service-based options issued, 129,729 service-based restricted common shares granted, 640,970 performance-based and 116,240 market-based restricted common shares granted under the 2012 Plan. As of November 30, 2016, there were 569,729 service-based options issued, 129,729 service-based restricted common shares granted, 630,970 performance-based and 116,240 market-based restricted common shares granted under the 2012 Plan.    As of August 31, 2017, there were 1,043,332 shares available for future issuance under the 2012 Plan.

Service-based vesting condition options

The fair value of each option award is estimated on the date of the grant using the Black-Scholes valuation model that uses the assumptions noted in the following table. Expected volatility is based on the historical volatility of the Company’s stock over the most recent period commensurate with the expected life of the Company’s stock options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected term of options granted to employees is calculated, in accordance with the “simplified method” for “plain vanilla” stock options allowed under GAAP. Expected dividends are based on the historical trend of the Company not issuing dividends.

There were 22,500 options granted during the three and nine months ended August 31, 2017, respectively.

There were 35,000 and 204,729 options granted during the three and nine months ended August 31, 2016, respectively.

 

Variables used to determine the fair value of the options granted for the three and nine months ended August 31, 2017 and August 31, 2016, respectively, are as follows:

 

     Three Months
Ended
    Three Months
Ended
    Nine Months
Ended
    Nine Months
Ended
 
     August 31, 2017     August 31, 2016     August 31, 2017     August 31, 2016  

Weighted average values:

        

Expected dividends

     0%       0%       0%       0%  

Expected volatility

     52.06%       66.09%       52.06%       66.39%  

Risk free interest rate

     1.82%       1.09%       1.82%       1.22%  

Expected life

     5.0 years       5.0 years       5.0 years       5.6 years  

Stock option activity for options with only service-based vesting conditions for the nine months ended August 31, 2017, was as follows:

 

            Weighted      Weighted
Average
        
            Average      Remaining      Aggregate  
     Shares      Exercise
Price
     Contractual
Term (Years)
     Intrinsic
Value
 

Outstanding at November 30, 2016

     1,142,010      $ 2.36        4.99      $ 2,157,112  

Granted

     22,500        7.00           —    

Exercised

     (26,781      1.92           78,149  

Expired/forfeited

     (7,500      1.66           38,150  
  

 

 

          

 

 

 

Outstanding at August 31, 2017

     1,130,229      $ 2.47        4.41      $ 4,844,612  
  

 

 

          

 

 

 

Exercisable at August 31, 2017

     1,044,697      $ 2.34        4.12      $ 4,610,775  
  

 

 

          

 

 

 

The weighted average grant date fair value of options granted during the nine months ended August 31, 2017 and August 31, 2016 was $3.25 and $1.86, respectively.

The aggregate intrinsic value represents the total value of the difference between the Company’s closing stock price on the last trading day of the period and the exercise price of the options, multiplied by the number of in-the-money stock options that would have been received by the option holders had all option holders exercised their options on either August 31, 2017 or November 30, 2016, as applicable. The intrinsic value of the Company’s stock options changes based on the closing price of the Company’s stock.

During the three and nine months ended August 31, 2017, the Company issued 0 and 26,781 common shares to option holders who exercised options for $0 and $51,396, respectively.

During the three and nine months ended August 31, 2016, the Company issued 23,399 common shares to option holders who exercised options for $40,340, respectively.

 

Significant option groups outstanding and exercisable at August 31, 2017 and related price and contractual life information are as follows:

 

     Outstanding      Exercisable  
            Weighted
Average
                      
            Remaining      Weighted             Weighted  

Range of Exercise Prices

   Outstanding      Contractual
Life (Years)
     Average
Exercise Price
     Outstanding      Average
Exercise Price
 

$1.01 to $ 2.00

     425,000        4.17      $ 1.73        425,000      $ 1.73  

$2.01 to $ 3.00

     455,500        2.81        2.58        455,500        2.58  

$3.01 to $4.00

     227,229        7.82        3.18        162,325        3.19  

$6.01 to $7.00

     22,500        6.89        7.00        1,872        7.00  
  

 

 

          

 

 

    
     1,130,229        4.41      $ 2.47        1,044,697      $ 2.34  
  

 

 

          

 

 

    

A summary of the status of the Company’s non-vested options as of August 31, 2017, and changes during the nine months ended August 31, 2017, is presented below:

 

            Weighted Average  
            Grant-Date  
     Shares      Fair Value  

Non-vested at November 30, 2016

     97,406      $ 1.84  

Granted

     22,500        3.25  

Vested

     (34,374      1.92  

Forfeited

     —          —    
  

 

 

    

 

 

 

Non-vested at August 31, 2017

     85,532      $ 2.18  
  

 

 

    

 

 

 

As of August 31, 2017, there was approximately $109,000 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2006 Plan and the 2012 Plan. The cost is expected to be recognized over a weighted-average period of .65 years as of August 31, 2017. The total fair value of shares vested during the nine months ended August 31, 2017 was approximately $66,000.

During the second fiscal quarter of 2016, the Company entered into Amended and Restated Employment Agreements (“2016 Employment Agreements”) with each of the Company’s Co-CEOs. Per the Employment Agreements, each of the Co-CEOs is to receive base grant equity awards in the form of qualified options of the Company’s common stock. As of April 15, 2016, David Portnoy and Mark Portnoy were granted 70,270 and 59,459 options of the Company’s common stock, respectively. The options were issued under the Company’s 2012 Stock Plan and will vest 1/3 upon grant, 1/3 on December 1, 2016 and the remaining 1/3 on November 30, 2017. The fair value of these options vested as of August 31, 2017 was approximately $213,000 and is reflected as selling, general and administrative expenses in the accompanying consolidated statement of comprehensive income (loss). As of August 31, 2017, there was approximately $31,000 of total unrecognized compensation cost related to the non-vested options of common stock and these will continue to vest as notated above and per the 2016 Employment Agreements through November 30, 2017.

Performance and market-based vesting condition options

There were no performance-based or market-based vesting condition options granted during the three months and nine months ended August 31, 2017 and August 31, 2016, respectively. As of August 31, 2017 and August 31, 2016, there were no performance or market-based vesting condition options outstanding.

 

Restricted common shares

During the first fiscal quarter of 2014, the Company entered into Amended and Restated Employment Agreements (“Employment Agreements”) with each of the Company’s Co-CEOs. The Employment Agreements provide for the grant of restricted shares of the Company’s common stock based on certain performance measures being attained by each of the Company’s Co-CEOs. The Employment Agreements provide that if David Portnoy and Mark Portnoy are employed by the Company on November 30, 2015, then no later than February 15, 2016, the Company will grant up to 186,487 and 162,163 shares of restricted common shares, respectively, based on certain performance thresholds, as defined in the agreements. The Company issued David Portnoy 118,062 shares and Mark Portnoy 102,663 shares during the first quarter of fiscal 2016. As of August 31, 2016, there was $0 of total unrecognized compensation cost related to the issuance of these shares of restricted common shares.

As of April 15, 2016, the Company entered into Amended and Restated Employment Agreements (“Employment Agreements”) with each of the Company’s Co-CEOs. The Employment Agreements provide for the grant of shares of the Company’s common stock based on certain performance measures being attained by each of the Company’s Co-CEOs during fiscal year 2016. The Employment Agreements state if David Portnoy and Mark Portnoy are employed by the Company on November 30, 2016, then no later than February 28, 2017, the Company will grant up to 186,487 and 162,163 shares of common stock. Based upon the performance measures being attained, the Company granted 183,145 and 159,257 shares of common stock to David Portnoy and Mark Portnoy, respectively. The fair value of the shares granted for fiscal 2016 was approximately $1,252,000 and was reflected as selling, general and administrative expense in the consolidated statements of comprehensive income (loss) for the year ended November 30, 2016. There was $0 of total unrecognized compensation cost related to the fiscal 2016 performance measures as of August 31, 2017. As of August 31, 2017, the Company has recognized approximately $542,000 of compensation cost related to the fiscal 2017 performance measures and there was approximately $181,000 in unrecognized compensation cost related to the fiscal 2017 performance measures.

As of April 18, 2016, the Company entered into a second Amendment Agreement (the “Amendment”), with the Company’s CIO Oleg Mikulinsky effective December 1, 2015, amending certain terms of the Amendment Agreement dated May 1, 2013 and Mikulinsky Employment Agreement dated March 5, 2012. The Amendment provides for the grant of shares of the Company’s common stock based on certain performance measures being attained by the Company during fiscal year 2016. The Amendment states if Executive is employed by the Company on November 30, 2016, then no later than February 28, 2017, the Company will grant Executive up to 20,000 shares of restricted stock based on performance as set forth in the Amendment. Based upon performance measures being attained, the Company granted 19,620 shares of common stock to Oleg Mikulinksy. The fair value of the shares granted was approximately $78,000. There was $0 of total unrecognized compensation cost as of August 31, 2017.